Immediate Impact
1 by Nobel laureates 57 standout
Citing Papers
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Works of Michaela L. Tsai being referenced
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
2020
A randomized phase II trial of CX-01 with standard therapy in elderly patients with acute myeloid leukemia (AML).
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michaela L. Tsai | 544 | 238 | 191 | 35 | 817 | |
| W.R. Bezwoda | 363 | 194 | 92 | 41 | 876 | |
| L. E. Shepherd | 528 | 305 | 184 | 42 | 788 | |
| Jamal Zekri | 614 | 133 | 344 | 63 | 889 | |
| Theodore A. Vandenberg | 450 | 158 | 107 | 26 | 752 | |
| L.V.A.M. Beex | 540 | 105 | 166 | 32 | 794 | |
| Rolando Nortilli | 606 | 264 | 114 | 36 | 794 | |
| Christine Elser | 458 | 162 | 229 | 43 | 879 | |
| Ayoub Charehbili | 507 | 462 | 126 | 34 | 880 | |
| G. Ucci | 353 | 137 | 132 | 61 | 921 | |
| Ásgerður Sverrisdóttir | 381 | 193 | 448 | 28 | 902 |
All Works
Loading papers...